Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.19 +0.43 (+0.37%)
Streaming Delayed Price Updated: 3:44 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
40 41 Next >
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Dividend Stocks That Are Investor Safe Havens
If there is such a thing as safe dividend stocks, these three should be at the top of your list to consider. 
Via InvestorPlace
1 Stock Down 15% This Year to Buy and Hold Forever
This stock has been delivering solid performances for a long time. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
SLB, Abbott And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
2 No-Brainer Dividend Stocks to Buy This Week
These two top-income stocks are too cheap to ignore. 
Via The Motley Fool
(ABT) - Analyzing Abbott Laboratories's Short Interest
Via Benzinga
Expert Ratings for Abbott Laboratories
Via Benzinga
MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024
Oppenheimer analyst Steven Lichtman reiterated the Outperform rating on DexCom, Inc. 
Via Benzinga
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
The market has punished them, but don't overlook these stocks. 
Via The Motley Fool
Are These 3 Dividend Aristocrats Undervalued Hidden Gems?
Dividend aristocrats Caterpillar, NextEra, and Clorox have shown resilience in challenging times. These may offer opportunities as they are trading off highs. 
Via MarketBeat
Exposures COVID-19
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.
Abbott Laboratories is getting into the consumer wearables market. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Abbott Laboratories (NYSE: ABT) Highlighted for Surprising Price Action
Via Investor Brand Network
Abbott Raises Outlook, Boosted By 'Whopping' Growth Of Diabetes Device
The company raised the midpoint of its earnings outlook. 
Via Investor's Business Daily
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
Via Talk Markets
Topics Economy
Exposures Economy
The Value Deepens for Medtech Stocks: Reversal Imminent
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows. 
Via MarketBeat
Stock Market Struggles As Treasury Yields Soar; Tesla, Nvidia Among Notable Losers: Weekly Review
The major indexes saw significant loses as Treasury yields soared. 
Via Investor's Business Daily
Abbott Laboratories's Earnings Outlook
Via Benzinga
A Look Into Abbott Laboratories Inc's Price Over Earnings
Via Benzinga
7 Blue-Chip Stocks to Buy on the Dip
While you can find plenty of ideas swimming in red ink, investors may find greater success with blue-chip stocks to buy on the dip. 
Via InvestorPlace
These Analysts Cut Their Forecasts On Abbott After Q3 Results
Abbott Laboratories (NYSE: ABT) reported better-than-expected third-quarter results. 
Via Benzinga
Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Abbott Stock Gains On Q3 Performance, 10% Organic Diagnostics Revenue Growth, Raised Annual Outlook
Abbott Laboratories (NYSE: ABT) has reported Q3 FY23 adjusted EPS of $1.14, almost similar to $1.15 a year ago, beating the con 
Via Benzinga
Oversold and Overextended, Abbott Laboratories is a Great Buy
Abbott Laboratories rises on solid results and guidance; the value and dividend are at the best levels in years, and the sell-side is buying. 
Via MarketBeat
Exposures COVID-19
US Stocks Set For Weak Open Ahead Of Tesla Q3 Print: Why This Analyst Is Skeptical Of S&P 500 Recovery To Early 2022 High
U.S. stocks faced another setback on Wednesday due to uncertainty surrounding interest rates and inflation. 
Via Benzinga
Topics Stocks
Exposures US Equities
Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns
Via Benzinga
Topics ETFs
Earnings Scheduled For October 18, 2023
Companies Reporting Before The Bell • Procter & Gamble (NYSE:PG) is expected to report quarterly earnings at $1.71 per share on revenue of $21.67 billion. 
Via Benzinga
Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate
(Monday market open) Last week gave us a taste of earnings. The meal starts tomorrow and picks up steam as banks, airlines, and health care companies report. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.